Merck has discontinued Recarbrio, a reserve IV antibiotic for resistant hospital infections, in the U.S. Here is what patients and families should know.
Merck Stops Selling Recarbrio in the U.S., Leaving Hospitals with Fewer Options for Drug-Resistant Pneumonia and Infections
by | Oct 1, 2026 | Uncategorized | 0 comments
Recent Comments